Stay updated with breaking news from Cold Syrup. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Central Drugs Standard Control Organisation (CDSCO) has sent the samples of the same batch of the four Maiden Pharmaceuticals Ltd-manufactured medicines, on which the WHO issued alert, for testing and further course of action will be ...
The ministry said that the WHO informed the DCGI the national drug regulator of India that it is currently providing technical assistance and advice to The Gambia where children have died and where a contributing factor is suspected to be the use of medicines which may have been contaminated with Diethylene glycol or Ethylene glycol
In a press release, the Union Health ministry said that the four syrups were manufactured only for exports and not licensed for sale in India.
National Regulatory Authority, CDSCO has requested the World Health Organization (WHO) to share the report on the establishment of causal relation to death with the medical products manufactured by a Haryana-based company, Maiden Pharmaceutical Limited, a press release said.
As per the tentative results received by WHO, out of the 23 samples of these products which were tested, 4 samples were found to contain Diethylene Glycol/ Ethylene Glycol. The exact one-to-one causal relation of death has not yet been provided by WHO to CDSCO, it said.